about
Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity.Advances in the diagnosis of adverse drug reactions.Clinical pharmacokinetics: current requirements and future perspectives from a regulatory point of view.Pharmacogenetics: part II: Perspective. 1992.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical consequences of polymorphic drug oxidation.
@en
Clinical consequences of polymorphic drug oxidation.
@nl
type
label
Clinical consequences of polymorphic drug oxidation.
@en
Clinical consequences of polymorphic drug oxidation.
@nl
prefLabel
Clinical consequences of polymorphic drug oxidation.
@en
Clinical consequences of polymorphic drug oxidation.
@nl
P2860
P1476
Clinical consequences of polymorphic drug oxidation.
@en
P2093
P2860
P304
P356
10.1111/J.1472-8206.1991.TB00713.X
P577
1991-01-01T00:00:00Z